Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

  • Roger Li
  • , Paras H. Shah
  • , Tyler F. Stewart
  • , Jong Kil Nam
  • , Trinity J. Bivalacqua
  • , Donald L. Lamm
  • , Edward M. Uchio
  • , Daniel M. Geynisman
  • , Joseph M. Jacob
  • , Joshua J. Meeks
  • , Rian Dickstein
  • , Shane M. Pearce
  • , Seok Ho Kang
  • , Seung Il Jung
  • , Ashish M. Kamat
  • , James M. Burke
  • , Kirk A. Keegan
  • , Gary D. Steinberg

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Fingerprint

Dive into the research topics of 'Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry